220 related articles for article (PubMed ID: 32655540)
1. The Clinical and Genetic Spectrum of 82 Patients With
Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
Front Immunol; 2020; 11():900. PubMed ID: 32655540
[No Abstract] [Full Text] [Related]
2. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
4. Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.
Szaflarska A; Rutkowska-Zapała M; Kotula M; Gruca A; Grabowska A; Lenart M; Surman M; Trzyna E; Mordel A; Pituch-Noworolska A; Siedlar M
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):177-183. PubMed ID: 28083621
[TBL] [Abstract][Full Text] [Related]
5. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.
Lugo-Reyes SO; Pastor N; González-Serrano E; Yamazaki-Nakashimada MA; Scheffler-Mendoza S; Berron-Ruiz L; Wakida G; Nuñez-Nuñez ME; Macias-Robles AP; Staines-Boone AT; Venegas-Montoya E; Alaez-Verson C; Molina-Garay C; Flores-Lagunes LL; Carrillo-Sanchez K; Niemela J; Rosenzweig SD; Gaytan P; Yañez JA; Martinez-Duncker I; Notarangelo LD; Espinosa-Padilla S; Cruz-Munoz ME
J Clin Immunol; 2021 Aug; 41(6):1291-1302. PubMed ID: 33954879
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.
Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I
Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703
[TBL] [Abstract][Full Text] [Related]
7. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
8. RAG-dependent primary immunodeficiencies.
Sobacchi C; Marrella V; Rucci F; Vezzoni P; Villa A
Hum Mutat; 2006 Dec; 27(12):1174-84. PubMed ID: 16960852
[TBL] [Abstract][Full Text] [Related]
9. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
11. Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients.
Cifaldi C; Rivalta B; Amodio D; Mattia A; Pacillo L; Di Cesare S; Chiriaco M; Ursu GM; Cotugno N; Giancotta C; Manno EC; Santilli V; Zangari P; Federica G; Palumbo G; Merli P; Palma P; Rossi P; Di Matteo G; Locatelli F; Finocchi A; Cancrini C
J Clin Immunol; 2022 Jan; 42(1):130-145. PubMed ID: 34664192
[TBL] [Abstract][Full Text] [Related]
12. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
13. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.
Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Steininger J; Sleasman JW; Parikh S; Dilley MA; Pai SY; Henderson L; Hazen M; Neven B; Moshous D; Sharapova SO; Mihailova S; Yankova P; Naumova E; Özen S; Byram K; Fernandez J; Wolf HM; Eibl MM; Notarangelo LD; Calabrese LH; Walter JE
Front Immunol; 2020; 11():574738. PubMed ID: 33193364
[TBL] [Abstract][Full Text] [Related]
14. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
15. Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.
Dorna MB; Barbosa PFA; Rangel-Santos A; Csomos K; Ujhazi B; Dasso JF; Thwaites D; Boyes J; Savic S; Walter JE
Front Pediatr; 2019; 7():122. PubMed ID: 31058115
[TBL] [Abstract][Full Text] [Related]
16. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
[TBL] [Abstract][Full Text] [Related]
17. Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine).
Sharapova SO; Guryanova IE; Pashchenko OE; Kondratenko IV; Kostyuchenko LV; Rodina YA; Varlamova TV; Bondarenko AV; Chernyshova LI; Gyseva MN; Belevtsev MV; Minakovskaya NV; Aleinikova OV
J Clin Immunol; 2016 Jan; 36(1):46-55. PubMed ID: 26596586
[TBL] [Abstract][Full Text] [Related]
18. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.
Tirosh I; Yamazaki Y; Frugoni F; Ververs FA; Allenspach EJ; Zhang Y; Burns S; Al-Herz W; Noroski L; Walter JE; Gennery AR; van der Burg M; Notarangelo LD; Lee YN
J Allergy Clin Immunol; 2019 Feb; 143(2):726-735. PubMed ID: 29772310
[TBL] [Abstract][Full Text] [Related]
19. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
20. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
